This post was originally published on this site
In a letter sent to GSK’s chairman Jonathan Symonds, Bluebell called for chief executive Emma Walmsley to reapply for her job as she would have “renewed credibility both internally and externally”, the FT report said.
Earlier this year, activist Elliott had also taken a stake in GSK, calling for a leadership change at the company.
